A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
about
P1343
Amplification and overexpression of prosaposin in prostate cancer.Lineage relationship of prostate cancer cell types based on gene expressionInhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genesOsteoblasts in prostate cancer metastasis to bone.Prostate cancer cell phenotypes based on AGR2 and CD10 expressionNeuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?Patient-Derived Prostate Cancer: from Basic Science to the Clinic.Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer.Next generation patient-derived prostate cancer xenograft models.Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.Establishment and serial passage of cell cultures derived from LuCaP xenografts.SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.The Genomics of Prostate Cancer: emerging understanding with technologic advances.Biology and evolution of poorly differentiated neuroendocrine tumors.Patient derived organoids to model rare prostate cancer phenotypes.
P2860
Q33221098-3E176F20-14E5-4D24-A00C-BF3C258C6A11Q33909346-D086206A-BC1A-4D49-AF62-54F77A59DC15Q35249241-5B437B5F-04C9-4C15-A660-0A9163E3C7F9Q35998759-646EA7E1-66D1-4588-BB6C-D3A12E7F5732Q36800218-8C3E9B93-0201-44A2-9ADD-065B672EF3DFQ37444366-9B6D3031-FDC4-4CD8-82B4-5B4A72E0AD7BQ37659820-0995C388-C735-4774-A024-BB273ACB3932Q38833940-DC14AD3D-FD51-4474-8A3F-BA99A1ADADA3Q38868832-08DC0999-BE48-4DC5-A2B6-FDC0CE429D28Q39673894-27FE1287-29F6-4CAC-9D69-0C0A0714930CQ40656134-8089D363-17C1-4070-8FFB-6C34146BBD97Q41902873-D4D9595E-90F1-4699-9B59-AFBA5C89D971Q42188512-7425ED62-EE2B-4CE5-8861-7A559A940139Q42315779-6C48478E-6992-4BC6-B88C-26AB01567324Q42467386-BBA4F612-E659-4BA9-9921-D7815AB87293Q48317607-3FB580AB-9DC7-4B53-A9DC-4828DD7167D8Q48320507-3CCE6292-0E4D-4EBA-BCAA-494C8BDEAA4BQ55367999-61975B17-4244-4276-A039-D0D8ABEA81D1
P2860
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@ast
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@en
type
label
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@ast
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@en
prefLabel
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@ast
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@en
P2093
P2860
P1476
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
@en
P2093
Emily Williams
Janna Quinn
Jill A Macoska
Kent Buhler
Lawrence D True
Nigel Clegg
Paul Lange
Peter S Nelson
Robert Vessella
P2860
P304
P356
10.1016/S0002-9440(10)64226-5
P407
P4510
P577
2002-08-01T00:00:00Z